These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9122204)

  • 21. Overexpression of CD109 in the Epidermis Differentially Regulates ALK1 Versus ALK5 Signaling and Modulates Extracellular Matrix Synthesis in the Skin.
    Vorstenbosch J; Nguyen CM; Zhou S; Seo YJ; Siblini A; Finnson KW; Bizet AA; Tran SD; Philip A
    J Invest Dermatol; 2017 Mar; 137(3):641-649. PubMed ID: 27866969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatocellular expression of a dominant-negative mutant TGF-beta type II receptor accelerates chemically induced hepatocarcinogenesis.
    Kanzler S; Meyer E; Lohse AW; Schirmacher P; Henninger J; Galle PR; Blessing M
    Oncogene; 2001 Aug; 20(36):5015-24. PubMed ID: 11526486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autocrine and exogenous transforming growth factor beta control cell cycle inhibition through pathways with different sensitivity.
    Wang J; Sergina N; Ko TC; Gong J; Brattain MG
    J Biol Chem; 2004 Sep; 279(38):40237-44. PubMed ID: 15271980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Demonstration that mutation of the type II transforming growth factor beta receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells.
    Wang J; Sun L; Myeroff L; Wang X; Gentry LE; Yang J; Liang J; Zborowska E; Markowitz S; Willson JK
    J Biol Chem; 1995 Sep; 270(37):22044-9. PubMed ID: 7665626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Healing of burn wounds in transgenic mice overexpressing transforming growth factor-beta 1 in the epidermis.
    Yang L; Chan T; Demare J; Iwashina T; Ghahary A; Scott PG; Tredget EE
    Am J Pathol; 2001 Dec; 159(6):2147-57. PubMed ID: 11733365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autocrine transforming growth factor-beta signaling mediates Smad-independent motility in human cancer cells.
    Dumont N; Bakin AV; Arteaga CL
    J Biol Chem; 2003 Jan; 278(5):3275-85. PubMed ID: 12421823
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression and autoregulation of transforming growth factor beta receptor mRNA in small-cell lung cancer cell lines.
    Nørgaard P; Spang-Thomsen M; Poulsen HS
    Br J Cancer; 1996 May; 73(9):1037-43. PubMed ID: 8624260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Colon cancer cells that are not growth inhibited by TGF-beta lack functional type I and type II TGF-beta receptors.
    MacKay SL; Yaswen LR; Tarnuzzer RW; Moldawer LL; Bland KI; Copeland EM; Schultz GS
    Ann Surg; 1995 Jun; 221(6):767-76; discussion 776-7. PubMed ID: 7794080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of protein tyrosine kinases attenuates increases in expression of transforming growth factor-beta isoforms and their receptors following arterial injury.
    Ward MR; Agrotis A; Kanellakis P; Dilley R; Jennings G; Bobik A
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2461-70. PubMed ID: 9409216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adenovirus-mediated transfer of a truncated transforming growth factor-beta (TGF-beta) type II receptor completely and specifically abolishes diverse signaling by TGF-beta in vascular wall cells in primary culture.
    Yamamoto H; Ueno H; Ooshima A; Takeshita A
    J Biol Chem; 1996 Jul; 271(27):16253-9. PubMed ID: 8663151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted expression of the E6 and E7 oncogenes of human papillomavirus type 16 in the epidermis of transgenic mice elicits generalized epidermal hyperplasia involving autocrine factors.
    Auewarakul P; Gissmann L; Cid-Arregui A
    Mol Cell Biol; 1994 Dec; 14(12):8250-8. PubMed ID: 7969162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A kinase-defective transforming growth factor-beta receptor type II is a dominant-negative regulator for human breast carcinoma MCF-7 cells.
    Ko Y; Koli KM; Banerji SS; Li W; Zborowska E; Willson JK; Brattain MG; Arteaga CL
    Int J Oncol; 1998 Jan; 12(1):87-94. PubMed ID: 9454891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of TGF-beta related Smad proteins in human epithelial skin tumors.
    Lange D; Persson U; Wollina U; ten Dijke P; Castelli E; Heldin CH; Funa K
    Int J Oncol; 1999 Jun; 14(6):1049-56. PubMed ID: 10339656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TGF beta regulation of cell proliferation.
    Moses HL; Arteaga CL; Alexandrow MG; Dagnino L; Kawabata M; Pierce DF; Serra R
    Princess Takamatsu Symp; 1994; 24():250-63. PubMed ID: 8983080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activin controls skin morphogenesis and wound repair predominantly via stromal cells and in a concentration-dependent manner via keratinocytes.
    Bamberger C; Schärer A; Antsiferova M; Tychsen B; Pankow S; Müller M; Rülicke T; Paus R; Werner S
    Am J Pathol; 2005 Sep; 167(3):733-47. PubMed ID: 16127153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose- and time-dependent expression of transforming growth factor-beta 1 mRNA and protein in mouse epidermis and papillomas after repeated topical application of benzo[a]pyrene.
    Sherman JH; Miller ML; Albert RE; Baxter CS
    Mol Carcinog; 1993; 8(4):264-71. PubMed ID: 8280374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mouse embryonic stem cells with aberrant transforming growth factor beta signalling exhibit impaired differentiation in vitro and in vivo.
    Goumans MJ; Ward-van Oostwaard D; Wianny F; Savatier P; Zwijsen A; Mummery C
    Differentiation; 1998 Jul; 63(3):101-13. PubMed ID: 9697304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anomalies of the TGF-beta postreceptor signaling pathway in ovarian cancer cell lines.
    Hu W; Wu W; Nash MA; Freedman RS; Kavanagh JJ; Verschraegen CF
    Anticancer Res; 2000; 20(2A):729-33. PubMed ID: 10810347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of expression of transforming growth factor beta in skin and skin tumors is associated with hyperproliferation and a high risk for malignant conversion.
    Glick AB; Kulkarni AB; Tennenbaum T; Hennings H; Flanders KC; O'Reilly M; Sporn MB; Karlsson S; Yuspa SH
    Proc Natl Acad Sci U S A; 1993 Jul; 90(13):6076-80. PubMed ID: 7687059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TGF-beta is required to maintain the pool of immature Langerhans cells in the epidermis.
    Kel JM; Girard-Madoux MJ; Reizis B; Clausen BE
    J Immunol; 2010 Sep; 185(6):3248-55. PubMed ID: 20713882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.